LNCaP-abl

Information for LNCaP-abl

Description

Source BRENDA Tissue Ontology (BTO)

ReMap Statistics

Datasets
12
Transcriptional Factors
7
Peaks
744,527
Non-redundant peaks
316,323

Description

Cell_name
LNCaP-abl
Category
Cancer cell line
Disease
NCIt; C4863; Prostate carcinoma
Sex_gender_of_cell
Male
Age_of_donor
50Y

External IDs

Cellosaurus
CVCL_4793
Experimental Factor
BRENDA Tissue
Wiki
LNCaP-abl
ATCC
LNCaP-abl
Synonyms
All peaks LNCaP-abl
Download BED file
Non redundant LNCaP-abl
Download BED file
CRMs LNCaP-abl
Download BED file
DOWNLOAD All ReMap
Go to catalogue

Datasets Table for LNCaP-abl

Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks
LNCaP-abl AR GEO Homo sapiens GSE39459 Download (69,336)
LNCaP-abl EZH2 GEO Homo sapiens GSE39459 Download (51,451)
LNCaP-abl SUZ12 GEO Homo sapiens GSE39459 Download (12,217)
LNCaP-abl CREB1 GEO Homo sapiens GSE63034 Download (27,249)
LNCaP-abl SHCTR CREB1 GEO Homo sapiens GSE63034 Download (52,281)
LNCaP-abl SHFOXA1 CREB1 GEO Homo sapiens GSE63034 Download (59,176)
LNCaP-abl FOXA1 GEO Homo sapiens GSE63034 Download (71,936)
LNCaP-abl SHCREB1 FOXA1 GEO Homo sapiens GSE63034 Download (176,338)
LNCaP-abl SHCTR FOXA1 GEO Homo sapiens GSE63034 Download (166,109)
LNCaP-abl E2F1 GEO Homo sapiens GSE67809 Download (5,767)
LNCaP-abl ETOH TRIM24 GEO Homo sapiens GSE69331 Download (22,611)
LNCaP-abl DMSO AR GEO Homo sapiens GSE80238 Download (30,056)
Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.